Trust Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Buy
1,118
+7
+0.6% +$1.51K 0.13% 87
2026
Q1
$242K Sell
1,111
-792
-42% -$176K 0.14% 86
2025
Q4
$435K Buy
1,903
+208
+12% +$47.4K 0.23% 73
2025
Q3
$392K Sell
1,695
-60
-3% -$12.2K 0.22% 75
2025
Q2
$326K Sell
1,755
-906
-34% -$168K 0.2% 81
2025
Q1
$558K Buy
+2,661
New +$517K 0.36% 68
2024
Q3
Sell
-1,413
Closed -$242K 120
2024
Q2
$242K Buy
+1,413
New +$234K 0.15% 87
2023
Q2
Sell
-10,275
Closed -$1.64M 95
2023
Q1
$1.64M Sell
10,275
-1,540
-13% -$235K 1.47% 16
2022
Q4
$1.91M Buy
11,815
+1,676
+17% +$257K 1.8% 9
2022
Q3
$1.36M Sell
10,139
-216
-2% -$31K 1.42% 12
2022
Q2
$1.59M Sell
10,355
-5
-0% -$764 1.52% 10
2022
Q1
$1.68M Buy
10,360
+114
+1% +$16.6K 1.37% 17
2021
Q4
$1.39M Buy
10,246
+108
+1% +$12.8K 1.09% 34
2021
Q3
$1.09M Sell
10,138
-259
-2% -$29.6K 0.98% 48
2021
Q2
$1.17M Buy
10,397
+519
+5% +$58.5K 1.04% 41
2021
Q1
$1.07M Buy
9,878
+1,325
+15% +$142K 1.05% 38
2020
Q4
$916K Buy
+8,553
New +$822K 0.93% 46

Other funds holding ABBV

Trust Investment Advisors's ABBV Position: Q2 2026 in Review

Trust Investment Advisors increased its AbbVie (ABBV) stake by 0.63% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,118 shares worth $281K. The position accounts for 0.13% of the portfolio, ranked #87.

Trust Investment Advisors first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.91M in Q4 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trust Investment Advisors held 1,118 shares of AbbVie worth $281K as of Q2 2026.
  • Trust Investment Advisors bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.13% of Trust Investment Advisors's portfolio in Q2 2026, its #87 holding.
  • Trust Investment Advisors first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
  • Trust Investment Advisors's AbbVie position peaked at $1.91M in Q4 2022.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trust Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.